The novel treatment of the medication represents a major development in the care of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide200166.glifeblog.com/40606048/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment